J-BNB - VPMThane.org

References:
1. Eric Jonasch, Frank G. Haluska .Interferon in Oncological Practice: Review of Interferon
Biology, Clinical Applications, and Toxicities. The Oncologist, Vol. 6, No. 1, 34-55, February
2001.
2. Several different types of interferon are now approved for use in humans .some pharmaceutical
forms of interferon shown in table 1. Multiferon — a brand name known generically as human
leukocyte interferon-alpha (HuIFN-alpha-Le)was approved for treatment of patients with high
risk (stage IIb–III) cutaneous melanoma, after two treatment cycles with dacarbazine.Pegintron
or PEGylated interferon-alpha-2b is effective in treatment of hepatitis C.^ Jamall IS, Yusuf S,
Azhar M, Jamall S (November 2008). "Is pegylated interferon superior to interferon, with
ribavarin, in chronic hepatitis C genotypes 2/3". World J. Gastroenterol. 14 (43): 6627–
31.doi:10.3748/wjg.14.6627. PMC 2773302. PMID 19034963.
3. "NIH Consensus Statement on Management of Hepatitis C: 2002". NIH Consens State Sci
Statements 19 (3): 1–46. 2002. PMID 14768714.
4. Sharieff KA, Duncan D, Younossi Z (February 2002). "Advances in treatment of chronic
hepatitis C: 'pegylated' interferons". Cleve Clin J Med69 (2):1559.
doi:10.3949/ccjm.69.2.155. PMID 11990646.
5. Schroder, K. et al. (2004) J LeukocBiol 75, 163-89.
6. Martinez, F.O. et al. (2009) Annu Rev Immunol 27, 451-83.
7. Kotenko, S.V. et al. (1995) J BiolChem 270, 20915-21.
8. McLaren, J.E. and Ramji, D.P. (2009) Cytokine Growth Factor Rev 20, 125-35.
9. deWeerd NA, Samarajiwa SA, Hertzog PJ (2007). "Type I interferon receptors: biochemistry and
biological functions". J Biol Chem 282 (28):20053-
20057. doi:10.1074/jbc.R700006200. PMID 17502368.
10. Liu YJ (2005). "IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic
cell precursors". Annu Rev Immunol 23: 275–
306.doi:10.1146/annurev.immunol.23.021704.115633. PMID 15771572.
55 JBNB (Vol. I ) Issue I January’2013